Thirteen billion clinical laboratory tests are performed annually in clinical laboratories nationwide. These test results are relied upon by thousands of physicians each and every day to make important decisions about diagnosis and treatment in collaboration with their patients, and COLA is honored to serve the tens of thousands of professionals involved in laboratory testing…
COLA’s “caregiver” takes her role very seriously
One new staffer hired, one current staffer promoted
The CDC has released the following diagnostic testing instructions for the Multistate Fungal Meningitis Outbreak Investigation. If you have any other questions please contact COLA directly at 1-800-981-9883. Diagnostic Testing for Septic Arthritis and Specimen Submission to CDC – Outbreak Associated with Injection of Potentially Contaminated Steroid Products The pathogens involved in this cluster of…
Executives of COLA, a national laboratory accreditor for quality laboratory medicine and patient care, will attend the 2019 Executive War College on Lab and Pathology Management being held at the Sheraton Hotel in New Orleans April 30 – May 1, 2019. The Executive War College is the premier conference for laboratory executives, administrators and pathologists…
COLA is launching a Waived Testing Pilot Program, designed to obtain laboratory feedback on a series of products for waived labs. Participating laboratories will receive complimentary lab resources, ranging from an on-site survey to enrollment in year-long Proficiency Testing, depending on the pilot program. We plan to conduct four pilot programs starting this fall. These include:…
Once again, COLA was visited by auditors from the British Standards Institution (BSI) relative to its certification under ISO standard: 9001 affecting quality management systems. COLA first received this important certification in 2011. During the audit, no nonconformities were found, and only a few additional opportunities for improvement were identified. COLA remains the only CMS-deemed…
COLA, a nationally recognized private, non-profit laboratory accreditation organization, recently sent a letter to the U.S. Government Accountability Office (GAO) requesting an expansion of its recent report on the implementation of rate cuts to the Clinical Laboratory Fee Schedule (CLFS) do to PAMA. The GAO, in a November 2018 report entitled, “Medicare Laboratory Tests: Implementation…
